PL EN


Preferences help
enabled [disable] Abstract
Number of results
2014 | 26 | 103 | 89-93
Article title

Caffeine and neurodegenerative disorders

Content
Title variants
Languages of publication
EN
Abstracts
EN
Neurodegenerative disorders are amongst the most dangerous diseases in modern society. At the end of 1990, adenosine receptor antagonists were used to block the adenosine A1 and A2A receptors causing less physical, cellular and molecular damage caused by Alzheimer’s and Parkinson’s diseases. In recent years, an increase in death rate caused by these diseases has been observed among people under 74. Caffeine, as NMDA receptor antagonist, prevents an uncontrolled influx of calcium ions into the interior of the cells exerting a neuroprotective effect and beneficial procognitive effects. There is much evidence that caffeine intake is associated with a reduced risk of Alzheimer’s and Parkinson’s diseases.
Year
Volume
26
Issue
103
Pages
89-93
Physical description
References
Document Type
article
Publication order reference
YADDA identifier
bwmeta1.element.psjd-d00f8b75-14fb-4345-82d7-b5d8e6568c9e
Identifiers
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.